Production (Stage)
Biohaven Ltd.
BHVN
$14.74
-$0.32-2.13%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -71.82% | -107.37% | -73.15% | -73.31% | 4.88% |
| Total Depreciation and Amortization | 29.01% | 13.64% | 35.92% | 62.63% | 140.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 167.71% | 432.76% | 90.49% | 77.73% | -64.37% |
| Change in Net Operating Assets | -121.58% | -31.70% | -56.36% | 75.04% | 270.92% |
| Cash from Operations | -80.80% | -75.58% | -80.18% | -63.87% | -12.71% |
| Capital Expenditure | -47.84% | -32.84% | -55.32% | 17.01% | 58.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -- | -- | -- | 101.12% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -165.79% | -281.61% | -23.34% | 97.57% | 163.35% |
| Cash from Investing | -169.20% | -288.69% | -23.75% | 95.21% | 153.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 170.20% | 172.98% | 125.87% | 99.04% | -12.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.18% | 100.30% | -96.54% | -109.56% | -112.56% |
| Cash from Financing | 257.63% | 219.84% | 30.85% | -20.17% | -75.54% |
| Foreign Exchange rate Adjustments | 120.08% | 115.09% | -233.47% | -228.72% | -216.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,202.32% | -1,671.86% | -150.92% | -77.32% | -102.45% |